canada clinical guidance

Diabetic foot problems (prevention + urgent assessment)

A Canadian clinical summary of diabetic foot problems (prevention + urgent assessment), with source-attributed priorities and explicit jurisdiction boundaries.

JurisdictionCanada
Source check2026-08-20
Clinical reviewiatroX editorial team 路 Clinical editorial review 路 reviewed 2026-08-20 路 due 2027-08-20
AudienceHealthcare professionals practising in Canada
This is an iatroX educational summary of named Canada sources, not an official guideline. It does not replace the complete source documents, local policy, specialist advice or clinical judgement. The evidence source is pan-Canadian, but formularies, funded access, referral routes, public-health directions and service availability remain provincial or territorial.

Source and scope

This summary is bounded to the recommendations, population and decisions covered by Foot Care. Apply it with the current provincial or territorial pathway where implementation differs.
sources for this section:Diabetes Canada foot care

Source-attributed clinical priorities

  • Screen feet for neuropathy, pulses, deformity, skin breakdown and footwear risk at guideline-recommended intervals.
  • Treat new ulceration, infection, ischemia or suspected Charcot neuroarthropathy as time-sensitive and offload appropriately.
  • Use a local multidisciplinary foot and vascular pathway; service configuration and urgent-access routes vary by province and territory.
  • Classify ulcer depth, infection and ischemia and document offloading and footwear at every review.
sources for this section:Diabetes Canada foot care

Practical assessment and management workflow

1
Inspect skin, deformity and footwear and test protective sensation and pedal perfusion.
2
For an ulcer, measure and photograph, probe when appropriate and assess infection and arterial supply.
3
Offload immediately and coordinate wound, vascular, infection, podiatry and diabetes treatment.
4
Reassess healing trajectory frequently and escalate failure to improve or deeper involvement.
sources for this section:Diabetes Canada foot care

Safety, red flags and urgent escalation

  • Escalate systemic infection, rapidly spreading cellulitis, gangrene, critical ischemia or suspected deep abscess.
  • Treat a warm swollen neuropathic foot as possible acute Charcot disease and immobilize pending assessment.
  • Do not culture or prescribe antibiotics for an uninfected ulcer solely because it is chronic.
sources for this section:Diabetes Canada foot care

Confirm the local pathway before acting

The evidence source is pan-Canadian, but formularies, funded access, referral routes, public-health directions and service availability remain provincial or territorial.
sources for this section:Diabetes Canada foot care

Source and implementation boundary

Read this educational summary with the linked source, current Canadian product information where medicines are involved, and the applicable provincial or territorial pathway. Local formularies, reporting duties, referral routes and service availability can differ.
sources for this section:Diabetes Canada foot care

Source documents

Use the linked source documents for complete recommendations, evidence grading, exclusions and implementation detail.

  1. Diabetes CanadaFoot CareCan J Diabetes 2018;42(Suppl 1):S222-S227; current official chapter checked 2026-08-20 路 accessed 2026-08-20
    view source
continue the learning

From guidance to deliberate practice and evidence

Choose what happens next. iatroX can carry this page's jurisdiction, source-check date and released version into an editable learning record, support your reflection, or let you browse the regional question bank while keeping this topic visible. No action records completion, starts a session or awards CPD/CME credit automatically.

Found a source update or regional discrepancy? Tell the iatroX editorial team.